New-Onset Atrial Fibrillation in Patients With Type 2 Diabetes Treated With Novel Glucose-Lowering Therapies.
Fu-Chih HsiaoKun-Chi YenTze-Fan ChaoShao-Wei ChenYi-Hsin ChanPao-Hsien ChuPublished in: The Journal of clinical endocrinology and metabolism (2022)
SGLT2is were associated with lower risk of new-onset AF compared with GLP-1RAs among patients with type 2 diabetes mellitus in a real-world practice.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- primary care
- left atrial appendage
- glycemic control
- blood glucose
- direct oral anticoagulants
- healthcare
- heart failure
- wild type
- percutaneous coronary intervention
- quality improvement
- cardiovascular risk factors
- newly diagnosed
- cardiovascular disease
- venous thromboembolism
- metabolic syndrome
- adipose tissue
- skeletal muscle
- insulin resistance